But the exact mechanisms of how the drug works in the brain in doing things like tamping down food noise, addiction, and now, ...

A new study suggests that two widely used Type 2 diabetes medications—GLP-1 receptor agonists and SGLT2 inhibitors—may help reduce the risk of Alzheimer’s disease and related dementias.

Is this the new Ozempic? The doctor who believes that peptides therapy could be the key to a longer life - The molecules ...

A study led by researchers in the University of Florida College of Pharmacy has found that a pair of popular glucose-lowering medications may have protective effects against the development of ...

Alzheimer's is the most common form of dementia ... which is the active ingredient in Ozempic and Wegovy. Ozempic is not marketed as a weight loss drug and is prescribed to those with type ...

The decision came in response to a February lawsuit from a compounding industry group against the FDA's decision that there ...

Jamie Mafdali of South Florida was hit with a cancer double-whammy three years ago. Shortly after her mother began treatment ...

Pa., said Mounjaro changed his life with 'significant' health benefits. He's calling for widespread access to GLP-1 ...

from reducing addictive behaviours to lowering the risk of Alzheimer’s disease. Research has found that weight-loss drugs such as Ozempic may help curb addictive behaviours, such as alcohol ...

Dementia, including Alzheimer’s disease and related disorders, is one of the fastest-growing public health concerns globally.

The state’s largest commercial health insurer will stop covering a popular class of prescription drugs for weight loss, ...